Medicenna Therapeutics Corp. - MDNAF

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$770K
QoQ value delta ($000)
-$338K (-30.51%)
Implied price effect (QoQ)
-39.72%
Shares
Total shares
2,677,282
QoQ shares delta
+354,897 (+15.28%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (MDNAF)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q4 2023 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Hudson Bay Capital Management LP 223 780,564 0.0%
Sigma Planning Corp 187 634,550 0.01%
Verition Fund Management LLC 158 555,392 0.0%
ROYAL BANK OF CANADA 51 173,945 0.0%
LETKO, BROSSEAU & ASSOCIATES INC 35 120,000 0.0%
Rathbones Group PLC 31 105,663 0.0%
RENAISSANCE TECHNOLOGIES LLC 25 85,113 0.0%
TOCQUEVILLE ASSET MANAGEMENT L.P. 23 79,000 0.0%
GEODE CAPITAL MANAGEMENT, LLC 9 34,144 0.0%
MILLENNIUM MANAGEMENT LLC 7 24,988 0.0%
CITADEL ADVISORS LLC 7 27,626 0.0%
OSAIC HOLDINGS, INC. 6 22,000 0.0%
GREAT VALLEY ADVISOR GROUP, INC. 5 19,500 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 3 10,605 0.0%
WELLS FARGO & COMPANY/MN 0 715 0.0%
MORGAN STANLEY 0 1,800 0.0%
TORONTO DOMINION BANK 0 1,677 0.0%